Clinical Trial Update: Randomized Control Trial on Seprafilm and Guardix in Preventing Ileus [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial evaluating Seprafilm and Guardix to prevent postoperative ileus following colorectal or gastric cancer surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• Guardix
• Seprafilm

Snippet

Sponsor: Gachon University Gil Medical Center | Conditions: Patient Under Going Colorectal and Stomach Cancer Surgery | Phase 3 | Status: COMPLETED